Search the Newsreel

VivoSim reports 13.4M shares outstanding after July warrant exercises

VivoSim (VIVS) announced it has regained compliance with Nasdaq Listing Rule 5550(b)(1) after receiving a $5.0 million milestone payment and $1.0 million escrow release from Eli Lilly, along with $3.6 million net proceeds from a financing. The company reported $10.1 million cash on hand …

Astera Labs, Inc. Stock 12‑Month Price Target Raised to $391.01, Implies 8% Upside

Astera Labs, Inc. (ALAB) has seen its average 12-month price target raised to $391.01 by 21 analysts, suggesting an 8% upside from its Aug. 4 closing price. The consensus rating for the stock remains a "Buy" from 24 analysts, with a breakdown of 15 …

Establishment Labs GAAP EPS of -$0.39 misses by $0.05, revenue of $67.5M beats by $1.72M

* Establishment Labs press release [https://seekingalpha.com/pr/20609818-establishment-labs-reports-second-quarter-2026-financial-results] (ESTA [https://seekingalpha.com/symbol/ESTA]): Q2 GAAP EPS of -$0.39 misses by $0.05. * Revenue of $67.5M (+31.6% Y/Y) beats by $1.72M. * $24.7 million of sales in the United States, up 26% from Q1 2026 * Guidance raised to $269 …

Up 58% in 12 Months, This Is Where Rocket Lab Will End The Year

Quick Read RKLB earns a BUY with an $82 year-end target, backed by 63% revenue growth and a record $2.2 billion backlog. ASTS posts just $15M in quarterly revenue on a $17.5B market cap, while Planet Labs carries roughly one-fifth of RKLB's $41B valuation. …

BioAge Labs Reports Q2 2026 Results, Doses First Patient in QUELL-CV and Advances BGE-102 Clinical Development

BioAge Labs announced its Q2 2026 results, reporting a net loss of $26.1 million, but also significant progress in its clinical trials. The company dosed the first patient in its QUELL-CV Phase 2 trial for BGE-102, targeting inflammation and cardiometabolic biomarkers, with topline data …

Astera Labs and Amphenol: Quiet AI Capex Tax Collectors to Know Before Others Catch On

The article analyzes Astera Labs (ALAB) and Amphenol (APH) as beneficiaries of AI infrastructure spending. Astera Labs, focused on AI fabric silicon, saw revenue double year over year, while Amphenol, with diversified offerings, grew 55% to $8.76 billion. The author suggests Astera offers higher …

Aurora Labs (ASX:A3D) Advances as Defence Additive Manufacturing Work Develops

Nanjing Leads Biolabs Advances Key Liver Cancer Trial for Opamtistomig

Jyothy Labs Share Price Today, Jyothy Labs Stock Price Live NSE/BSE Updates

ViewBix Ord Shs (QXL) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for ViewBix Ord Shs (QXL), detailing future EPS and revenue growth estimates. It includes a snapshot of the stock's current market performance, key financial metrics, and a peer comparison with other companies in the Software & IT Services …

Quantum X Labs (Nasdaq:QXL) - Stock Analysis

This report provides a comprehensive stock analysis of Quantum X Labs (Nasdaq:QXL), detailing its market capitalization, financial health, past performance, and recent developments. The company, focused on quantum technology and AI solutions, has a market cap of US$61.3 million and has seen its share …

Earnings Flash (ESTA) Establishment Labs Holdings Inc. Reports Q2 Revenue $67.5M, vs. FactSet Est of $65.8M

Establishment Labs Holdings Inc. (ESTA) announced Q2 revenue of $67.5 million, surpassing FactSet's estimate of $65.8 million. The company also reported a net loss of $0.39 per share for Q2, which was higher than FactSet's estimated loss of $0.34 per share. Additionally, Establishment Labs …

Nvidia, Micron, and Sandisk Are Up Over 1,000% Since the AI Boom Started. These 2 AI Stocks Could Be the Next Big Winners.

Key Points Astera and Arista, companies focused on connectivity and networking solutions, should benefit as AI workloads proliferate and models become more complex. Astera Labs designs specialized semiconductors and software that improve connectivity and data transmision across GPUs, CPUs, memory, and storage. Arista Networks …

Nano Labs joins Canton Network as Validator Node, boosting institutional blockchain infrastructure.

Nano Labs Ltd. has been approved as a Validator Node on the Canton Network, a blockchain platform utilized by major financial institutions. This strategic move aims to enhance Nano Labs' role in developing secure and compliant digital asset infrastructure for institutional use. The company …

BioAge Labs Q2 NetLoss Expands; Expects QUELL-CV Phase 2 Results Of BGE-102 In H2 2026

(RTTNews) - BioAge Labs, Inc. (BIOA), a clinical-stage biopharmaceutical company, reported second-quarter financial results reflecting a wider net loss despite a marginal increase in collaboration-based revenue. BioAge develops therapeutic product candidates for cardiometabolic diseases. BioAge's lead product candidate, BGE-102, is a potent, orally bioavailable, …

Nanjing Leads Biolabs Advances Liver Cancer Drug to Phase 2 Expansion

Establishment Labs (NASDAQ:ESTA) Price Target Raised to $95.00 at Needham & Company LLC

Establishment Labs Q2 Revenue Rises 31.7 Percent

Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates

Here's Why We're Watching Aurora Labs' (ASX:A3D) Cash Burn Situation

Blend Labs (NYSE:BLND) Issues Quarterly Earnings Results

Blend Labs (BLND) Reports Break-Even Earnings for Q2

Earnings Preview: Absci Corp to Report Financial Results Post-market on August 11

Absci Corp (ABSI) is scheduled to report its financial results post-market on August 11. Analysts expect the company to post a GAAP EPS of -$0.17 for the second quarter, with revenue projections around $2.31 million. The article provides details on the company's past earnings …

VivoSim Labs issues 9,896,718 shares on warrant exercises

VivoSim Labs issued 9,896,718 common shares between July 15 and July 31, 2026, due to the exercise of warrants. This issuance significantly increased the shares outstanding to 13,390,789 as of August 3, 2026, up from 3,194,295 on June 30, 2026. The warrant exercises followed …

Tranche Update on Blend Labs, Inc.'s Equity Buyback Plan announced on March 10, 2026.

Blend Labs, Inc. has provided an update on its equity buyback plan announced on March 10, 2026. Between April 1, 2026, and June 30, 2026, the company repurchased 12,178,000 shares for $20.14 million. This brings the total repurchased shares under the plan to 22,219,000 …

Astera Labs Stock Rises 13% After Strong Guidance and Quarterly Earnings Beat

BioAge Labs (NASDAQ:BIOA) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

THNC: Plus segment growth and AI innovation drove Q2 revenue and profitability gains

BioAge Labs, Inc. reports results for the quarter ended June 30 - Earnings Summary

BioAge Labs, Inc. has released its earnings summary for the quarter that concluded on June 30. The article, sourced from Reuters and published on TradingView, provides an overview of the company's financial performance. Readers are encouraged to access the full article on TradingView for …

BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates

BioAge Labs reported its second-quarter 2026 financial results, highlighting progress in its clinical development programs for BGE-102, an oral NLRP3 inhibitor. The company announced the first participant dosed in its QUELL-CV Phase 2 trial for obesity and inflammation, with topline data expected in late …

BioAge Labs (NASDAQ: BIOA) builds $381.3M cash buffer as BGE-102 advances

BioAge Labs reported a net loss of $48.4 million for the first half of 2026 but holds a strong cash position of $381.3 million, expected to fund operations through 2029. The company is advancing its lead candidate BGE-102, an NLRP3 inhibitor, with positive Phase …

BioAge's BGE-102 Enters Obesity Trial; Eye Study Planned

BioAge Labs reported a Q2 2026 net loss of $26.1 million on collaboration revenue of $2.4 million, with increased R&D expenses driven by its BGE-102 program. The company has dosed the first participant in its Phase 2 QUELL-CV trial for obesity with inflammation, expecting …

Joseph B. Hayek and Suresh Krishna Join Apogee Enterprises’ Board of Directors

MINNEAPOLIS, August 05, 2026--(BUSINESS WIRE)--Apogee Enterprises, Inc. (Nasdaq: APOG), a leading provider of architectural building products and services, as well as high-performance coated materials used in a variety of applications, announced today that its Board of Directors has elected Joseph B. Hayek, President and …

Thinkific Labs Inc. Provides Earnings Guidance for the Third Quarter of 2026

Astera Labs Stock Strategy Etches Path Toward A Large Return Or Discounted Shares

Astera Labs stock spiked 12.7% on Tuesday after the company surpassed Wall Street's targets in its latest earnings announcement. Investors could buy Astera Labs at the current price or use options to potentially buy shares of the semiconductor company for a discount. Astera Labs …

Proto Labs (PRLB) insider Kenison plans $947K stock sale in Form 144

Proto Labs (PRLB) shareholder Michael R. Kenison has filed a Form 144, indicating a planned sale of 10,753 shares of common stock valued at approximately $947,786.62 through Morgan Stanley Smith Barney LLC on the NYSE. The filing also details Kenison's prior acquisitions through restricted …